Clough Capital Partners L P Sells 6,280 Shares of Encompass Health Corporation $EHC

Clough Capital Partners L P reduced its stake in shares of Encompass Health Corporation (NYSE:EHC) by 6.2% in the third quarter, HoldingsChannel reports. The institutional investor owned 95,501 shares of the company’s stock after selling 6,280 shares during the period. Clough Capital Partners L P’s holdings in Encompass Health were worth $12,131,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Alliancebernstein L.P. boosted its position in shares of Encompass Health by 23.4% during the third quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock worth $319,567,000 after acquiring an additional 476,564 shares during the last quarter. Geode Capital Management LLC grew its stake in Encompass Health by 0.5% during the second quarter. Geode Capital Management LLC now owns 1,773,547 shares of the company’s stock valued at $217,526,000 after acquiring an additional 8,765 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Encompass Health by 0.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,616,178 shares of the company’s stock valued at $205,279,000 after acquiring an additional 7,349 shares during the last quarter. Raymond James Financial Inc. lifted its stake in Encompass Health by 34.8% in the 3rd quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock worth $195,780,000 after purchasing an additional 397,694 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Encompass Health by 5.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock valued at $179,141,000 after purchasing an additional 70,387 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Insider Transactions at Encompass Health

In related news, CEO Mark J. Tarr sold 150,000 shares of Encompass Health stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the completion of the transaction, the chief executive officer directly owned 377,070 shares of the company’s stock, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Treasurer Edmund Fay sold 11,937 shares of the company’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the transaction, the treasurer owned 89,325 shares in the company, valued at $9,557,775. The trade was a 11.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 2.00% of the stock is currently owned by insiders.

Encompass Health Stock Performance

NYSE EHC opened at $100.52 on Friday. The business’s 50 day moving average price is $103.58 and its 200-day moving average price is $112.98. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The company has a market cap of $9.99 billion, a P/E ratio of 18.14, a P/E/G ratio of 1.92 and a beta of 0.71. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The company had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same period last year, the company earned $1.17 earnings per share. Encompass Health’s revenue was up 9.9% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Sell-side analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be paid a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, April 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.8%. Encompass Health’s payout ratio is currently 13.72%.

Wall Street Analysts Forecast Growth

EHC has been the subject of a number of research analyst reports. Barclays raised their price objective on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research report on Friday, February 6th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Finally, Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Encompass Health has a consensus rating of “Buy” and an average target price of $143.29.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.